Cryopyrin-associated periodic syndrome primary prevention

Revision as of 19:18, 1 July 2019 by Sahar Memar Montazerin (talk | contribs) (Created page with "__NOTOC__ {{cryopyrin-associated periodic syndrome}} {{CMG}}; {{AE}} {{Sahar}} ==Overview== *There are no established measures for the primary prevention of cryopyrin-associa...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Cryopyrin-associated periodic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryopyrin-associated periodic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryopyrin-associated periodic syndrome primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryopyrin-associated periodic syndrome primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryopyrin-associated periodic syndrome primary prevention

CDC on Cryopyrin-associated periodic syndrome primary prevention

Cryopyrin-associated periodic syndrome primary prevention in the news

Blogs on Cryopyrin-associated periodic syndrome primary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Cryopyrin-associated periodic syndrome primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Overview

  • There are no established measures for the primary prevention of cryopyrin-associated periodic syndrome.

Secondary Prevention

  • There are no established measures for the primary prevention of cryopyrin-associated periodic syndrome.

References

Template:WH Template:WS